CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma

CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma

Subpopulations of nasopharyngeal carcinoma (NPC) contain cells with differential tumourigenic properties. Our study evaluates the tumourigenic potential of CD24, CD44, EpCAM and combination of EpCAM/CD44 cells in NPC. CD44br and EpCAMbr cells enriched for higher S-phase cell content, faster-growing...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Author: Hoe S.L.L.; Tan L.P.; Abdul Aziz N.; Liew K.; Teow S.-Y.; Abdul Razak F.R.; Chin Y.M.; Mohamed Shahrehan N.A.; Chu T.L.; Mohd Kornain N.K.; Peh S.-C.; Koay C.E.; Lo K.-W.; Ahmad M.; Ng C.-C.; Khoo A.S.-B.
Format: Article
Language:English
Published: Nature Publishing Group 2017
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030111011&doi=10.1038%2fs41598-017-12045-8&partnerID=40&md5=2157dcea8e84de26e7b653c4e14969a0

Internet

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030111011&doi=10.1038%2fs41598-017-12045-8&partnerID=40&md5=2157dcea8e84de26e7b653c4e14969a0

Similar Items